By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

The latest health news covers FDA's extended review of KalVista's drug, UroGen's new bladder cancer treatment approval, ...